Vsevolod Katritch
Affiliations: | MCB | University of Southern California, Los Angeles, CA, United States |
Google:
"Vsevolod Katritch"Parents
Sign in to add mentor| Andrzej Stasiak | grad student | 1990-1995 | University of Lausanne + EPFL |
| Jacques Dubochet | post-doc | 1995-1997 | DBCM, Université de Lausanne, Switzerland (Chemistry Tree) |
| Raymond C. Stevens | post-doc | 2003-2007 | UCSD, Scripps Institute (Chemistry Tree) |
| Ruben Abagyan | research scientist | 2003-2007 | University of California |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shin J, Park J, Jeong J, et al. (2024) Constitutive activation mechanism of a class C GPCR. Nature Structural & Molecular Biology |
| García-Nafría J, Arroyo-Urea S, Nazarova A, et al. (2023) Structure of the dopamine D3 receptor bound to a bitopic agonist reveals a new specificity site in an expanded allosteric pocket. Research Square |
| Bonifazi A, Saab E, Sanchez J, et al. (2023) Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D (DR) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics. Journal of Medicinal Chemistry |
| Han J, Zhang J, Nazarova AL, et al. (2023) Ligand and G-protein selectivity in the κ-opioid receptor. Nature |
| Zhang D, Liu Y, Zaidi SA, et al. (2023) Structural insights into angiotensin receptor signaling modulation by balanced and biased agonists. The Embo Journal. e112940 |
| El Daibani A, Paggi JM, Kim K, et al. (2023) Molecular mechanism of biased signaling at the kappa opioid receptor. Nature Communications. 14: 1338 |
| Aydin Y, Böttke T, Lam JH, et al. (2023) Structural details of a Class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in living cells. Nature Communications. 14: 1151 |
| Faouzi A, Wang H, Zaidi SA, et al. (2022) Structure-based design of bitopic ligands for the µ-opioid receptor. Nature |
| Perryman R, Renziehausen A, Shaye H, et al. (2022) Inhibition of the angiotensin II type 2 receptor ATR is a novel therapeutic strategy for glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. 119: e2116289119 |
| Zhang S, Chen H, Zhang C, et al. (2022) Inactive and active state structures template selective tools for the human 5-HT receptor. Nature Structural & Molecular Biology. 29: 677-687 |